Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells
Background: Vγ9Vδ2 T-cells demonstrate potent antitumor activity in vitro but, despite successful safety studies, the clinical benefit of Vγ9Vδ2 in adoptive cell therapy has been limited. One approach to enhance the therapeutic potential of Vγ9Vδ2 T-cells while maintaining their safety profile is ge...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-06-01
|
| Serie: | Immuno-Oncology and Technology |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2590018825000139 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|